Research
Print page Print page
Switch language
Hvidovre Hospital - a part of Copenhagen University Hospital
Published

High-risk and low-risk human papillomavirus and the absolute risk of cervical intraepithelial neoplasia or cancer

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Subcuticular suture compared with staples for skin closure after cesarean delivery: A randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effect of smoking cessation on gestational and postpartum weight gain and neonatal birth weight

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Awareness of endometrial cancer risk and compliance with screening in hereditary nonpolyposis colorectal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Cytokines and the Risk of Preterm Delivery in Twin Pregnancies

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Louise Thomsen
  • Kirsten Frederiksen
  • Christian Munk
  • Jette Junge
  • Philip E Castle
  • Thomas Iftner
  • Susanne K Kjaer
View graph of relations

OBJECTIVE: To determine the absolute risk of cervical intraepithelial neoplasia (CIN) grade 3 or cervical cancer (CIN 3 or worse) after detection of low-risk human papillomavirus (HPV) and after a negative high-risk HPV test.

METHODS: In this prospective cohort study, consecutive liquid-based cervical cytology samples were collected from women screened for cervical cancer in Copenhagen, Denmark, during 2002-2005. Samples were tested with a clinical test for 13 high-risk and five low-risk HPV types. The cohort (N=35,539; aged 14-90 years) was monitored in a nationwide pathology register for up to 10.5 years for development of CIN 3 or worse.

RESULTS: The 8-year absolute risk of CIN 3 or worse was 1.1% (95% confidence interval [CI] 1.0-1.3%) for HPV-negative women; 1.7% (0.8-2.6%) for low-risk HPV-positive women without concurrent high-risk HPV; 17.4% (16.4-18.5%) for high-risk HPV-positive women without concurrent low-risk HPV; and 15.9% (13.5-18.3%) for women with concurrent high-risk and low-risk HPV. The 8-year absolute risk of CIN 3 or worse after a negative high-risk HPV test (irrespective of low-risk HPV status) was lower than after a normal cytology result among women aged younger than 30 years (3.5% [95% CI, 2.9-4.0%] compared with 6.9% [6.2-7.5%], P<.001) and women aged 30 years or older (0.7% [95% CI, 0.6-0.9%] compared with 1.8% [95% CI, 1.6-2.0%], P<.001).

CONCLUSION: A negative high-risk HPV test provides greater long-term reassurance against CIN 3 or worse than normal cytology. Detection of low-risk HPV does not predict CIN 3 or worse. Cervical cancer screening should not include testing for low-risk HPV types.

LEVEL OF EVIDENCE: II.

Original languageEnglish
JournalObstetrics and Gynecology
Volume123
Issue number1
Pages (from-to)57-64
Number of pages8
ISSN0029-7844
DOIs
Publication statusPublished - Jan 2014

    Research areas

  • Adolescent, Adult, Aged, Aged, 80 and over, Cervical Intraepithelial Neoplasia, Cervix Uteri, Denmark, Female, Humans, Middle Aged, Papillomaviridae, Prospective Studies, Risk Assessment, Uterine Cervical Neoplasms, Young Adult

ID: 44464477